Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Swiss approval for Novartis’ Tasigna

August 31, 2010 Sales and Marketing Novartis, Tasigna, Tekamlo

Novartis’ Tasigna has received its first European approval as a first-line treatment after Swiss authorities green-lighted the blood cancer drug …
News

Sanofi’s $18.5bn bid for Genzyme rejected

August 31, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …
News

US prescription drug prices rise above inflation

August 27, 2010 Sales and Marketing US, prices

A new study of US medicines has found that prices rose 8.3% on average in 2009, well above inflation and …
News

US court bars stem cell funding

August 26, 2010 Sales and Marketing Obama, Stem cells, US

A US district court has temporarily blocked plans to increase government funding of stem cell research in the country. The ruling …
News

Alcon acquisition makes Novartis eyecare leader

August 26, 2010 Sales and Marketing Novartis, ophthalmology

Novartis has finalised its takeover of Alcon that will make it the world’s number one company in ophthalmology. Alcon is …
News
Velcade

Janssen to appeal against Velcade decision

August 26, 2010 Medical Communications, Sales and Marketing NICE, Thalidomide, Velcade, multiple myeloma

Celgene’s Thalidomide has been recommended by NICE for multiple myeloma ahead of Janssen-Cilag’s Velcade. A final appraisal determination says that …
News

NICE updates guidance for arthritis treatments

August 26, 2010 Sales and Marketing NICE, Roche, rheumatoid arthritis

Five new drugs for rheumatoid arthritis have been given the thumbs up by NICE as second line treatment. Roche’s MabThera, …
News
Multaq

Multaq given limited approval from NICE

August 25, 2010 Medical Communications, Sales and Marketing Multaq, NICE, Sanofi-Aventis, atrial, dronedarone

NICE has given a restricted approval to Sanofi-Aventis’s Multaq as a second line treatment for atrial fibrillation patients. The guidance …
News

Avastin patient access scheme too complicated, says NICE

August 25, 2010 Sales and Marketing NICE, avastin, patient access

NICE is set to say no again to Avastin for use in patients with colorectal cancer. Avastin was first launched …
News

Roche signs $1bn peptide deal with Aileron

August 25, 2010 Research and Development, Sales and Marketing Aileron, Roche, peptide, stapled peptide therapeutics

Roche has entered an agreement with a US biopharma company Aileron Therapeutics to develop and commercialise drugs called Stapled Peptide …
News

Sutent disappoints in lung cancer

August 24, 2010 Research and Development, Sales and Marketing NSCLC, Pfizer, Sutent, Tarceva

Pfizer’s Sutent has failed to improve overall survival in lung cancer patients when combined with Roche’s Tarceva. Pfizer’s SUN 1087 …
News

Avandia letter misleading, FDA tells Glaxo

August 24, 2010 Sales and Marketing Avandia, GSK

GlaxoSmithKline’s travails over controversial diabetes drug Avandia show no sign of abating as members of a key regulatory panel accused …
News
PakistanFloodWEB

Pharma provides aid for Pakistan

August 24, 2010 Sales and Marketing GSK, NGO, Novartis, Pakistan, disaster, pharma, relief

 The pharma industry is providing donations to help those affected by the mass flooding across Pakistan. As many as 20 …
News

Encouraging data for Eisai epilepsy drug

August 24, 2010 Sales and Marketing Eisai, epilepsy, perampanel, phase III, seizures, study 306

A new phase III study for Eisai’s perampanel (E2007) suggests the first-in-class treatment is effective as an adjunctive treatment of …
News

GSK shingles vaccine enters late stage trials

August 23, 2010 Research and Development, Sales and Marketing GSK, Vaccine, shingles

GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026